Isotretinoin therapy and the incidence of acne relapse: a nested case–control study
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Previous studies on predictors of acne relapse in patients treated with isotretinoin had either small sample sizes, short follow-up periods, or lacked population-based data. OBJECTIVES: To identify and quantify predictors of acne relapse, and predictors of receiving a second isotretinoin treatment. METHODS: Using the Régie de l'Assurance Maladie du Québec (RAMQ) and Quebec's hospital discharge (Med-Echo) administrative databases, a population-based cohort of 17 351 first-time isotretinoin users was assembled between 1984 and 2003. A nested case-control analysis was performed to determine predictors of acne relapse (as defined by receiving an antiacne medication). A second nested case-control analysis was performed to determine predictors of receiving a second isotretinoin treatment. The index date of cases was the calendar date of dispensing an antiacne medication (isotretinoin or other). Five controls were matched to each case on follow-up time. Rate ratios were estimated using conditional logistic regression. RESULTS: A total of 7100 (41%) subjects experienced an acne relapse. These were matched to 35 500 controls. Being male, under 16 years of age and living in an urban area, and receiving isotretinoin cumulative doses greater than 2450 mg and an isotretinoin treatment longer than 121 days were statistically associated (P < 0.05) with acne relapse. The publishing of the different Canadian acne guidelines had no impact on the incidence of acne relapse (P > 0.05). A total of 4443 (26%) subjects required a second isotretinoin treatment. These were matched to 22 215 controls. There was a greater probability of receiving a second isotretinoin treatment after the publishing of the Canadian acne guidelines (P < 0.05). CONCLUSION: A relatively high rate of subjects experienced an acne relapse after an isotretinoin treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tamblyn, R., Lavoie, G., Petrella, L., & Monette, J. (1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)00234-h · Cited by 577
Cited by
The use of isotretinoin in acne
Layton, A. (2009) · Dermato-Endocrinology · doi:10.4161/derm.1.3.9364 · Cited by 314
Lee, J. W., Yoo, K. H., Park, K. Y., Han, T. Y., Li, K., Seo, S. J., & Hong, C. K. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.10152.x · Cited by 127
Acne Management Guidelines by the Dermatological Society of Singapore.
(2019) · PubMed Central · Cited by 74
Bray, A. P., Kravvas, G., Skevington, S. M., & Lovell, C. R. (2019) · Journal of Dermatological Treatment · doi:10.1080/09546634.2019.1577545 · Cited by 21
Metadata
- Authors
- Azoulay, L., Oraichi, D., & Bérard, A.
- Venue
- British Journal of Dermatology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-12
- Volume
- 157
- Issue
- 6
- Pages
- 1240-1248
- ISSN
- 0007-0963 (ISSN-L)
- 1365-2133
- OpenAlex
- W2146675394
- Cited by
- 77
- References
- 1
- FWCI
- 5.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Isotretinoin therapy and the incidence of acne relapse: a nested case–control study. https://app.cochat.ai/papers/10.1111/j.1365-2133.2007.08250.x
- The paper
- Azoulay, L., Oraichi, D., & Bérard, A. (2007). Isotretinoin therapy and the incidence of acne relapse: a nested case–control study. British Journal of Dermatology. https://doi.org/10.1111/j.1365-2133.2007.08250.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.